Journal
PEDIATRIC BLOOD & CANCER
Volume 58, Issue 4, Pages 489-491Publisher
WILEY PERIODICALS, INC
DOI: 10.1002/pbc.24060
Keywords
ATM; brainstem; PI3KCA; stereotactic biopsy; targeted therapy; TP53
Categories
Funding
- Charity l'Etoile de Martin
- French National Cancer Agency (INCa)
Ask authors/readers for more resources
Diffuse intrinsic pontine gliomas (DIPG) can not be cured with current treatment modalities. Targeted therapy in this disease would benefit from advanced technologies detecting relevant drugable mutations. Twenty patients with classic newly diagnosed DIPG underwent stereotactic biopsies and were analyzed for the presence of 983 different mutations in 115 oncogenes and tumor-suppressor genes using OncoMap, a mass spectrometric method of allele detection. Our results identified oncogenic mutations in TP53 (40%), PI3KCA (15%), and ATM/MPL (5%) while none were identified in a large number of other genes commonly mutated in malignant gliomas. The identification of oncogenic mutations in the PI3K pathway offers the potential of a therapeutic target at initial diagnosis in this devastating disease. Pediatr Blood Cancer 2012; 58: 489491. (c) 2011 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available